Having trouble viewing this e-mail? CLICK HERE
 
Pharm Tech
May 2020
Volume 44, No. 5
VIEW ONLINE ARCHIVE SUBSCRIBE FORWARD Twitter LinkedIn

Notice to Pharmaceutical Technology subscribers currently receiving printed copies of the magazine:

Many readers working remotely may not have access to the print versions of Pharmaceutical Technology; therefore, for upcoming issues, we will deliver the digital version of the magazine to you via email. Your print issues will continue to be delivered to you via postal mail and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form.


| COVER STORY |

Technology Advances Streamline Bioprocessing

Feliza Mirasol

Bioprocessing advances improve product yield, cut costs, and streamline integration between upstream and downstream processes.
read more


| DEVELOPMENT |

Formulating an ADC Development Solution

Cynthia A. Challener

Many antibody-drug conjugate therapies are in the pipeline; however, only a handful have been approved. What are the bottlenecks?
read more

PharmTech May Issue
Read the issue online Subscribe or renew your Pharm Tech subscription

A Welcome Change: The Benefits of Reformulation

Felicity Thomas

Reformulation strategies can provide drug developers with a head start to achieve promising options that benefit the patient.
read more


| MANUFACTURING |

Manufacturing Microneedle Array Patches for Vaccine Delivery

Jennifer Markarian

Equipment and process optimization must be considered for scaling up these developmental technologies to commercial production.
read more


How a Contamination Control Program Impacts Product Sterility

Aaron Mertens, Joe McCall

A well-defined contamination control program is essential to maintain quality through aseptic manufacture of parenteral drug products.
read more


| PEER-REVIEWED RESEARCH |

Determining the Probability of Passing USP Content Uniformity and Dissolution (Immediate and Extended) Tests with CuDAL-Excel

Lei Lei, Pramote Cholayudth

The CuDAL-Excel program, based on Microsoft (MS) Excel, has been developed to calculate the United States Pharmacopeia (USP) passing probability of content uniformity and dissolution tests for both sampling plan 1 and sampling plan 2 scenarios and for both immediate release and extended release requirements. The users can obtain the passing probability by simply entering the input variables, with wide applications for process validation/verification and batch release. As a user-friendly program, CuDAL Excel should bring more benefits to the industry practitioners than other existing programs/tools.
read more


| ANALYTICS |

Contamination Drives a More Concerted Approach to Genotoxins

Agnes Shanley

Discovery of carcinogenic nitrosamines in three of the world’s most widely prescribed drugs is driving efforts to better detect, control and prevent their generation in APIs and finished drug products.
read more


| OPERATIONS |

The Limits of Light Obscuration

Brent Denton, John Bak, Jonathon Salsbury

Light obscuration testing is the preferred method of sub-visible particle quantification but is not suitable for every preparation.
read more


| OUTSOURCING |

Ensuring Smooth Tech Transfer of Bioprocesses to Outsourcing Partners

Cynthia A. Challener

Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
read more


| FROM THE EDITOR |

How Fast Is Too Fast?

Rita C. Peters

Will moving at “warp speed” to develop a vaccine impact efficacy or safety?
read more


| US REGULATORY WATCH |

Modern Drug Manufacturing Key to COVID-19 Response

Jill Wechsler

Policy makers seek to ensure supplies of new therapies and to limit shortages.
read more


| ASK THE EXPERT |

Starting a Career in the Bio/Pharmaceutical Industry

Siegfried Schmitt

Having a better understanding about compliance will be of benefit when looking for a job or for furthering one’s career, says Siegfried Schmitt, PhD, vice-president, technical, Parexel Consulting.
read more


WEBCASTS

Best Practices for Meeting and Exceeding Regulatory Standards in Primary Packaging USP <381> and <382>
Part II: Wednesday, July 22, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
Register now


Practical Considerations for Bringing Drug Candidates to Phase I Clinical Trial
Wednesday, May 27, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


Ensuring Integrity of Drug Formulation from Development to QC
Thursday, May 21, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
Register now


Analysis of Genotoxic Nitrosamine Impurities in Pharmaceutical Products under GMP Conditions using High-Resolution Accurate Mass (HRAM) Mass Spectrometry
Wednesday, May 13, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


Bulletproof your Supply Chain: Hope for the Best, Prepare for the Worst
Monday, May 18, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


Through Container Verification of Pharmaceutical Raw Materials with the New Agilent Vaya Handheld Raman System
Europe Broadcast: Thursday, May 14, 2020 at 9am EDT | 2pm BST | 3pm CEST
US Broadcast: Thursday, May 14, 2020 at 2pm EDT | 1pm CDT | 11am PDT
Asia Pacific Broadcast: Friday, May 15, 2020 at 8:30am IST | 11am CST | 12pm JST | 1pm AEST
Register now


When Drug Meets Device: How to Assess Compatibility
Tuesday, May 19, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


| Events |

BIO Digital

June 8-2, 2020

Interphex 2020

July 15-17, 2020

69th PDA Annual Meeting

July 20-22, 2020

more events
Contribute an article | contact the editors | contact sales | subscribe | advertise